Next Article in Journal
Vaccine Delivery Methods into the Future
Previous Article in Journal
Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8+ T Lymphocytes in the Female Reproductive Tract
Article Menu

Export Article

Open AccessReview
Vaccines 2016, 4(2), 8; doi:10.3390/vaccines4020008

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies

1
Laboratory of DC-Biology, Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Hartmannstr. 14, Erlangen 91052, Germany
2
Centre d’Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM-CNRS, Marseille-Luminy 13288, France
*
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Received: 19 February 2016 / Revised: 15 March 2016 / Accepted: 18 March 2016 / Published: 28 March 2016
View Full-Text   |   Download PDF [694 KB, uploaded 28 March 2016]   |  

Abstract

Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have utilized this approach of antigen delivery to various kinds of endocytic receptors of DCs both in vitro and in vivo. Today, it is widely accepted that different DC subsets are important for the induction of select immune responses. Nevertheless, many questions still remain to be answered, such as the actual influence of the targeted receptor on the initiation of the immune response to the delivered antigen. Further efforts to better understand the induction of antigen-specific immune responses will support the transfer of this knowledge into novel treatment strategies for human diseases. In this review, we will discuss the state-of-the-art aspects of the basic principles of antibody mediated antigen targeting approaches. A table will also provide a broad overview of the latest studies using antigen targeting including addressed DC subset, targeted receptors, outcome, and applied coupling techniques. View Full-Text
Keywords: antigen targeting; antigen targeting antibodies; cancer; CLR; DC; DCIR; DEC205; dendritic cell subsets; moDC; vaccine antigen targeting; antigen targeting antibodies; cancer; CLR; DC; DCIR; DEC205; dendritic cell subsets; moDC; vaccine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lehmann, C.H.K.; Heger, L.; Heidkamp, G.F.; Baranska, A.; Lühr, J.J.; Hoffmann, A.; Dudziak, D. Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies. Vaccines 2016, 4, 8.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top